🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Status
Unknown
Location
Medical University of Innsbruck, Department for Internal Medicine I
Start Date
2010-03
Trial ID
NCT01166035
Treatments Being Tested
The purpose of this study is to find a safe, tolerable, and efficacious dos...
Status
Terminated
Location
Local Institution - 0047
Start Date
2023-11-09
Trial ID
NCT06024174
Treatments Being Tested
This is an open-label, non-randomized Phase II study to evaluate immunochem...
Status
Completed
Location
Interdisziplinäres Tumorzentrum (Comprehensive Cancer Center)
Start Date
2006-10
Trial ID
NCT00395252
Treatments Being Tested
The purpose of this interventional study is to assess the progression free ...
Status
Unknown
Location
Universitätsmedizin Mainz
Start Date
2011-01
Trial ID
NCT01315990
Treatments Being Tested
The purpose of this study is to learn about the effects of three study medi...
Status
Active Not Recruiting
Location
Mayo Clinic Building - Phoenix
Start Date
2022-07-11
Trial ID
NCT05217446
Treatments Being Tested
Study BT-CL-PGG-CRC0821 is a Phase 2, open-label, multicenter, efficacy and...
Status
Completed
Location
University of Minnesota
Start Date
2009-06
Trial ID
NCT00912327
Treatments Being Tested
This is a phase 1/2, multi-center study with an open-label, dose escalation...
Status
Completed
Location
California Cancer Associates for Research and Excellence
Start Date
2020-09-03
Trial ID
NCT04474470
Treatments Being Tested
The primary objective of this trial is to assess the antitumor activity and...
Status
Completed
Location
Cancer Institute & Hospital, Chinese Academy of Medical Sciences
Start Date
2009-12
Trial ID
NCT01177956
Treatments Being Tested
The purpose of this Phase I/II study is to define the maximum tolerated dos...
Status
Completed
Location
Winship Cancer Institute of Emory University
Start Date
2014-06-17
Trial ID
NCT02101034
Treatments Being Tested
To find the highest and/or recommended dose of TROP2-CAR-NK cells combined ...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-12-02
Trial ID
NCT06358430